Current Hematologic Malignancy Reports Q3区

期刊简介

his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

他的杂志旨在提供清晰，有见地，平衡的国际专家的贡献，审查最重要的，最近发表的临床发现有关的诊断，治疗，管理和预防血液恶性肿瘤。我们通过任命国际权威人士担任部分编辑的关键主题领域，如白血病，淋巴瘤，骨髓瘤，和T细胞和其他淋巴增生性恶性肿瘤的目标。而版块编辑则会选择一些主题，让顶尖专家为这些主题撰写全面的评论文章，这些文章强调新的发展和最近发表的重要论文，并通过注释参考文献列表突出显示。一个国际编辑委员会审查年度目录，建议他们国家/地区特别感兴趣的文章，并确保主题是最新的，包括新兴的研究。还提供了该领域知名人士的评论。

《Current Hematologic Malignancy Reports》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： AMERICAN MATHEMATICAL MONTHLY
• 下一篇：Patient-Patient Centered Outcomes Research